Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease

JOURNAL OF THE NEUROLOGICAL SCIENCES

卷:240

Article

Tang, K ; Hynan, LS ; Baskin, F ; Rosenberg, RN

关键词: Alzheimer's disease;    platelets;    beta-amyloid;    beta-secretase;    alpha-secretase;    APP;   

DOI  :  10.1016/j.jns.2005.09.002

来源: Elsevier

【 摘 要 】

The amyloid precursor protein (APP) in brain is processed either by an amyloidogenic pathway by beta-secretase and gamma-secretase to yield A beta (beta-amyloid 4 kDa) peptide or by a-secretase within the beta-amyloid domain to yield non-amyloidogenic products. We have studied blood platelet levels of a 22-kDa fragment containing the A beta (beta-amyloid 4 kDa) peptide, beta-secretase (BACE1), alpha-secretase (ADAM10). and APP isoform ratios of the 120-130 kDa to 110 kDa peptides from 31 Alzheimer's disease (AD) patients and 10 age-matched healthy control subjects. We found increased levels of A beta 4, increased activation of beta-secretase (BACE1), decreased activation of a-secretase (ADAM 10) and decreased APP ratios in AD patients compared to normal control subjects. These observations indicate that the blood platelet APP is processed by the same amyloidogenic and non-amyloidogenic pathways as utilized in brain and that APP processing in AD patients is altered compared to control subjects and may be a useful bio-marker for the diagnosis of AD, the progression of disease and for monitoring drug responses in clinical trials. (c) 2005 Elsevier B.V. All rights reserved.

【 授权许可】

Free